The National Academy of Sports Medicine (NASM) has introduced a new course titled ‘Understanding Weight Loss Medications: A Guide for Fitness and Wellness Professionals.’ This educational initiative aims at equipping professionals with the knowledge to support clients using GLP-1/GIP agonists, such as semaglutide and tirzepatide. These medications, which are widely used for obesity management and type 2 diabetes, have seen significant adoption, with reports indicating that 6% of U.S. adults are currently using them.

The ‘Understanding Weight Loss Medications: A Guide for Fitness and Wellness Professionals’ course provides an evidence-based review of these drugs, covering their mechanisms, benefits, potential side effects, and implications for weight loss. It also emphasizes the role of fitness and wellness professionals in guiding clients through exercise, nutrition, and behavioral strategies to enhance overall well-being during medically assisted weight loss.

Image Credit: NASM